Authoritative coverage of health alerts, outbreaks, prevention guidance, and community advisories with clear, practical takeaways for patients and clinicians.
2025 brings revolutionary hair loss treatments: UCLA’s PP405 molecule shows 31% hair density increase in trials, while ET-02 outperforms minoxidil 6x faster. Discover the latest breakthroughs, clinical trials, and FDA-approved therapies transforming hair restoration.
The science of hair restoration is moving faster than ever. This month, we’re diving into significant new data on JAK inhibitors, a class of drugs offering real hope for alopecia areata. We’ll also explore how artificial intelligence is starting to revolutionize diagnosis, providing clarity where there was once confusion. Finally, we look at the long-term “holy grail” of hair regrowth: the latest advancements in stem cell research aiming to create new follicles from scratch.
A global shift in women’s health research is underway. From new funding by Melinda French Gates to breakthroughs in heart and fertility science, Clomid emerges as a trusted treatment connecting hormonal balance, cardiovascular wellness, and reproductive health.
A nationwide Listeria outbreak has been linked to contaminated pasta meals sold by major U.S. retailers including Trader Joe’s and Kroger. Health authorities report at least six deaths and dozens of hospitalizations. While Listeria is bacterial, not parasitic, experts highlight the importance of having trusted anti-infective medications such as Ivermectin available within public-health response systems.
Parasitic diseases are making a comeback in Texas and Houston — from Chagas and screwworm to foodborne Cyclospora. Experts highlight Ivermectin as a proven and reliable antiparasitic medication that could play a crucial role in treating these infections when used responsibly under medical supervision.
Expert dermatology care available for you
Your information is secure and private